Arkolith/Insider Trading/RLMD/Form 4

Traversa Sergio

Chief Executive Officer, DirectorRELMADA THERAPEUTICS, INC. (RLMD) · full profile →Form 4 · filed Sep 11, 2024
Net Buying
Open-Market Buys
$395K
Open-Market Sells
$0
Net Open-Market Flow
$395K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2024Buy(P)51K$2.99$154K384K
Sep 10, 2024Buy(P)33K$2.75$91K333K
Sep 9, 2024Buy(P)56K$2.71$151K300K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-077795) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML